Feature
A contrast MRI can predict which heart patients with atrial fibrillation are most likely to benefit from catheter ablation, according to a multi-center study published in the Journal of the American Medical Association.
February 10, 2014
Feature
Massachusetts General Hospital conducted a biomarker-guided therapy study of chronic heart failure patients with left ventricular systolic dysfunction over a 10-month period. Results of “Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15 and Highly Sensitive Troponin T Measurement in Patients with Chronic Heart Failure” were published in JACC: Heart Failure. The report demonstrated that of all biomarkers evaluated, only serial testing of ST2 enhanced prognostic information over baseline concentrations and predicted change in left ventricular function.
February 10, 2014Feature
Traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near-term cardiovascular risk in employed populations, according to Jake Orville, CEO of Cleveland HeartLab (CHL). This position is supported by data from the American Heart Association. AHA reported 50 percent of all heart attacks and strokes occur in individuals with normal cholesterol and – for approximately 30 percent of patients with cardiovascular disease – their first sign of disease is death.
February 10, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Feature
Achieving real quality improvement and reducing costs means re-evaluating what constitutes value, according to a new paper e-published in the journal Catheterization and Cardiovascular Interventions (CCI). A new formula to define value, as presented in the paper, equates “real value” with appropriateness together with clinically defined outcomes and patient-expected outcomes relative to costs.
February 10, 2014
News
On-X Life Technologies Inc. received CE marking for an expanded labeling claim of its On-X Prosthetic Heart Valve. The company may market its mechanical heart valve in Europe with areduced requirement for the use of blood-thinning drugs such as warfarin. The On-X Plus 1.5 Aortic Heart Valve allows patients to be managed at INR (international normalized ratio) levels as low as 1.5.
February 10, 2014
News
Aetna issued a positive coverage policy for long-term continuous monitoring of patients with suspected heart arrhythmias, which includes use of the iRhythm Technologies’ ZIO Service. The new policy now makes iRhythm’s solution – comprised of the ZIO Patch, proprietary algorithms and the ZIO report – available as a potential covered service for the insurer’s medical members.
February 10, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
Scientists at Icahn School of Medicine at Mount Sinai may have developed a tissue model for the human heart that can bridge the gap between animal models and human clinical trial patients. Mount Sinai researchers generated their engineered cardiac tissue from human embryonic stem cells. The resulting muscle has remarkable similarities to native heart muscle, including the ability to beat and contract like the human heart. This research study was highlighted as the cover story of the February 2014 issue of The FASEB Journal.
February 07, 2014News
CardioDx Inc. is a molecular diagnostics company specializing in cardiovascular genomics. It published an analysis demonstrating that the Corus CAD gene expression score is significantly associated with plaque burden and luminal stenosis. The holds true in symptomatic patients being evaluated for obstructive coronary artery disease (CAD), as measured by CT-angiography. The study, "A Peripheral Blood Gene Expression Score is Associated with Atherosclerotic Plaque Burden and Stenosis by Cardiovascular CT-Angiography," appears online in the journal Atherosclerosis.
February 07, 2014News
Biotronik, a manufacturer of implantable cardiac devices and wireless remote monitoring technologies, has been added to the list of cardiac rhythm management (CRM) device suppliers to the U.S. Department of Veterans Affairs (VA).
February 07, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Raissa Rocha
Advancements in technologies are paving the way for many healthcare providers to connect with patients outside their hospitals more quickly and efficiently. For cardiology departments, technologies that allow for video collaboration, rapid transmission of scans and images and other forms of telemedicine are supporting the initiative to improve productivity, an initiative many are striving for as the U.S. healthcare landscape continues reform.
February 07, 2014
News
At Johnston Medical Center in Smithfield N.C., StatVideo’s EchoCart streams real-time images of babies’ hearts and live video conferencing over the web to pediatric cardiologists at Duke Children’s Hospital. EchoCart is a telemedicine system designed specifically for tele-echocardiography.
February 07, 2014
Technology
Vascular Solutions Inc. launched the ThrombiDisc topical hemostat designed for use around indwelling lines up to 12°F. ThrombiDisc contains both the power of thrombin to facilitate hemostasis and the antimicrobial properties of silver.
February 07, 2014Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
After several months of intense review and assessment of its specialized worker training program by an independent agency, Operon Resource Management of Lowell, Mass. received ISO 13485 certification.
February 07, 2014
News
A University of Utah-led study for treatment of patients with atrial fibrillation (A-fib) provides strong clinical evidence for the use of 3-D MRI to individualize disease management and improve outcomes. Results of the Delayed-Enhancement MRI Determinant of Successful Radio-frequency Catheter Ablation of Atrial Fibrillation (DECAFF) study will be published in the Journal of the American Medical Association.
February 07, 2014News
eCardio Diagnostics is opening its second Independent Diagnostic Testing Facility (IDTF) in San Francisco, Calif. Its first IDTF is located in Houston, Texas.
February 07, 2014